PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy. david.dellamorte@uniroma2.it.\', \'Department of Neurology, Evelyn F. McKnight Brain Institute, Miller School of Medicine, University of Miami, Miami, FL, USA. david.dellamorte@uniroma2.it.\', \'Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Rome, Italy. david.dellamorte@uniroma2.it.\', \'Interdisciplinary Center for Advanced Studies on Lab-on-Chip and Organ-on-Chip Applications (ICLOC), University of Rome Tor Vergata, Rome, Italy. david.dellamorte@uniroma2.it.\', \'Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.\', \'Diabetes Research Institute, Cell Transplant Center, Miller School of Medicine, University of Miami, Miami, FL, USA.\', \'Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy.\', \'Department of Medical Sciences, Fondazione Policlinico Tor Vergata, Rome, Italy.\', \'Clinical and Molecular Epidemiology, IRCCS San Raffaele Roma, Rome, Italy.\', \'Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Rome, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41419-021-04070-3
?:doi
?:hasPublicationType
?:journal
  • Cell death & disease
is ?:pmid of
?:pmid
?:pmid
  • 34354045
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Low level of plasminogen increases risk for mortality in COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all